Filing Details

Accession Number:
0001290929-23-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-13 21:41:29
Reporting Period:
2023-02-10
Accepted Time:
2023-02-13 21:41:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
316253 Enzo Biochem Inc ENZ Services-Medical Laboratories (8071) 132866202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1419248 G. James Wolf 105, Flyway Drive
Kiawah Island SC 29455
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2023-02-10 5,000 $1.29 4,095,000 No 4 P Direct
Common Stock, $0.01 Par Value Acquisiton 2023-02-13 5,000 $1.29 4,100,000 No 4 P Direct
Common Stock, $0.01 Par Value Acquisiton 2023-02-13 5,000 $1.29 115,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.01 Par Value Long Call Option (right to buy) Disposition 2023-02-13 324 $0.19 32,400 $5.00
Common Stock, $0.01 Par Value Short Put Option (obligation to buy) Acquisiton 2023-02-13 324 $1.01 32,400 $2.50
Common Stock, $0.01 Par Value Short Put Option (obligation to buy) Disposition 2023-02-13 750 $0.03 75,000 $7.50
Common Stock, $0.01 Par Value Short Put Option (obligation to buy) Acquisiton 2023-02-13 750 $1.12 75,000 $2.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
483 2022-10-28 2023-04-21 No 4 S Direct
324 2023-02-13 2023-07-21 No 4 S Direct
0 2022-10-28 2023-04-21 No 4 S Direct
2,163 2023-02-13 2023-04-21 No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.01 Par Value 308,500 Indirect See Footnote
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock, $0.01 Par Value Long Call Option (right to buy) $2.50 2022-10-28 2023-04-21 100,000 1,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2023-04-21 100,000 1,000 Direct
Footnotes
  1. The transaction was completed in the name and for the benefit of the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report will not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  2. The 308,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse and 170,500 shares owned directly by adult children of the Reporting Person.